Literature DB >> 9928209

The risk of using baboons as transplant donors. Exogenous and endogenous viruses.

J S Allan1.   

Abstract

African nonhuman primates harbor several exogenous and endogenous retroviruses which deserve further consideration in the transplant setting. In particular, simian foamy viruses (SFV), simian T-cell lymphotropic virus (STLV), baboon endogenous virus (BaEV), and simian endogenous retrovirus (SERV) are all carried by baboons and may be transmitted to humans by transplantation. We have found baboons to have high seroprevalence rates to both SFV and STLV, and molecular and serologic methods have been developed to detect such agents. In addition, current nonhuman primate breeding programs have thus far not focused on eliminating these viruses. In summary, the close genetic relationship with humans and number of persistent viral infections in baboons translates into a much greater infectious disease risk when compared to that of other domesticated species.

Entities:  

Mesh:

Year:  1998        PMID: 9928209     DOI: 10.1111/j.1749-6632.1998.tb09120.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

Review 1.  Infectious disease issues in xenotransplantation.

Authors:  R S Boneva; T M Folks; L E Chapman
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 2.  Current status of xenotransplantation and prospects for clinical application.

Authors:  Richard N Pierson; Anthony Dorling; David Ayares; Michael A Rees; Jörg D Seebach; Jay A Fishman; Bernhard J Hering; David K C Cooper
Journal:  Xenotransplantation       Date:  2009 Sep-Oct       Impact factor: 3.907

3.  Current status of xenotransplantation.

Authors:  Richard N Pierson
Journal:  JAMA       Date:  2009-03-04       Impact factor: 56.272

Review 4.  Cardiac xenotransplantation: a promising way to treat advanced heart failure.

Authors:  Songren Shu; Jie Ren; Jiangping Song
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

Review 5.  Biological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health Biotechnology.

Authors:  Ana Cláudia Coelho; Juan García Díez
Journal:  Front Bioeng Biotechnol       Date:  2015-04-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.